Your session is about to expire
← Back to Search
Pegylated liposomal doxorubicin for Breast Cancer
Study Summary
This trial is looking at whether a certain protein has an effect on how well chemotherapy works in treating breast cancer.
- Breast Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 3 trial • 366 Patients • NCT02631876Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the margin of safety for Pegylated liposomal doxorubicin?
"Pegylated liposomal doxorubicin is in Phase 2 of clinical trials, which means that while there is some safety data, none exists to support efficacy. Our team rates it as a 2 on our 1-3 scale."
What types of cancers does Pegylated liposomal doxorubicin show efficacy against?
"Pegylated liposomal doxorubicin is an effective treatment method for various types of cancer, including lymphoma, hodgkins, carcinoma, bronchogenic, and neuroblastoma (nb)."
To your knowledge, are there other clinical trials like this one?
"As of right now, there are 381 active trials for Pegylated liposomal doxorubicin in 67 countries and 1935 cities. The first ever trial involving this medication was sponsored by Alfacell Corporation and completed back in 1997. That initial study had 300 participants and successfully made it to Phase 3 approval. In the 23 years since that landmark clinical trial, 678 more have been conducted."
Are there any other similar clinical trials that have used Pegylated liposomal doxorubicin?
"Pegylated liposomal doxorubicin was first studied in 1997. So far, there have been a total of 678 completed studies. As of now, 381 clinical trials are still recruiting patients. Many of these studies are based in Tucson, Arizona."
How many participants are needed for this research project?
"Patients are not being actively recruited for this trial at the moment. This study was first posted on November 5th, 2013 and was last edited on June 1st, 2022. However, there are currently 2698 trials related to breast cancer and 381 trials concerning Pegylated liposomal doxorubicin that are recruiting patients."
Are there any patients still needed for this research project?
"The clinical trial in question is no longer recruiting patients, as evidenced by the fact that it was last updated on 6/1/2022. This particular study was posted on 11/5/2013. There are currently 3079 other trials enrolling patients."
Share this study with friends
Copy Link
Messenger